DCM
IMGN

Delpha Capital Management’s Immunogen Inc IMGN Stock Holding History

Delpha Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,589
Closed -$74K – 1331
2017
Q4 		$74K Buy
+11,589
New +$71.5K 0.08% 191

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Delpha Capital Management's IMGN Position: Q1 2018 in Review

Delpha Capital Management sold out of Immunogen Inc (IMGN) in Q1 2018, closing a stake of 11,589 shares — an estimated $74K sold.

Delpha Capital Management first reported a position in IMGN in Q4 2017 and held it in 1 quarter. The position peaked at $74K in Q4 2017. 204 funds tracked by Wall St. Rank hold IMGN as of Q1 2018.

  • Delpha Capital Management reported no remaining Immunogen Inc position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 11,589 Immunogen Inc shares in Q1 2018, an estimated $74K.
  • Delpha Capital Management first reported a position in Immunogen Inc in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Immunogen Inc position peaked at $74K in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.